System Alert Microsoft Internet Explorer (IE) is scheduled to be retired on June 15, 2022. Therefore, we are requesting the EHBs users' community to discontinue using IE and begin using other freely available browsers such as Microsoft Edge, Google Chrome, or Mozilla Firefox. If you experience any technical difficulties while using the above recommended browsers, please reach out to EHBs Customer Support Center for assistance.
Skip to Main Content

HRSA Electronic Handbooks

Funding Cycle View

Expand

Sickle Cell Disease Newborn Screening Follow-up Program

  • Program Name:Sickle Cell Disease Newborn Screening Follow-up Program
  • Activity Code:D1J
  • Application Available:2/22/2021
  • Application Deadline:4/29/2021
  • Created By:Schwab, Dawn
  • Created On:11/7/2019
  • Last Updated by:User, Administrator
  • Last Updated On:6/25/2021
  • Estimated Project Start Date:9/1/2021
 
Collapse

 Details of the changes posted in this announcement

Not Available
 
Collapse

 Announcement Information

Announcement Number HRSA-21-036
Announcement Code
CFDA Number 93.110
Provisional No
Activity Code D1J
Competitive Yes
Fiscal Year 2021
 
Collapse

 Purpose

This notice announces the opportunity to apply for funding under the Sickle Cell Disease Newborn Screening Follow-up Program (Follow-Up Program). The purpose of the Follow-Up Program is to facilitate access to quality sickle cell disease (SCD) care by: 1) conducting outreach and working with individuals and families with SCD from the time a newborn screen identifies a child with possible SCD, through diagnosis, treatment and follow-up; 2) providing education to families and providers; 3) disseminating resources; 4) collaborating with state newborn screening programs; and 5) linking individuals and families to community resources, evidence-based SCD care, and care coordination within the communities where they reside to the fullest extent possible.
 
Collapse

 Application Information

Application Available 02/22/2021
Application Deadline 04/29/2021
Supplemental Application Deadline N/A
Explanation for Deadline N/A
Archive Date 06/28/2021
Letter of Intent Not required
Application Package SF424
Allow Applications to be Reopened in EHBs No
FOA Available Yes
Competitive Application Types Supported New
Allow Electronic Submission N/A
Page Limit for Application
Attachments
70
Allow Multiple Applications
from an Organization from Grants.gov
No
Electronic Submission Instruction Electronic submission is/will be available in Grants.Gov
 
Collapse

 General Information

Projected Award Date N/A
Estimated Project Period N/A
Estimated Project Start Date 09/01/2021
Estimated Project End Date 08/30/2026
Estimated Amount of this Competition $3,680,000.00
Estimated Number of Awards 20
Estimated Average Size of Awards $0.00
Cost Sharing No
Cooperative Agreement No
 
Collapse

 Contact Information

Name Hakim Fobia
Email hfobia@hrsa.gov
Phone Number (301) 945-9842
 
Collapse

 Download Information

Expand FOA (Guidance) Attachment (Maximum 1)
Document Name Size Date Attached Description
MCHB HRSA-21-036 (U38) Sickle Cell Follow Up Program_Final.pdf 391 kB 02/22/2021
Expand Application Package (Maximum 1)
No documents attached
Expand User Guide (Maximum 1)
No documents attached


Scroll to top